China-based health services and distribution giant Baheal Pharmaceutical Group has entered into a partnership with the China unit of Japan-based Takeda Pharmaceutical Co., Ltd. The financial details of the deal were not disclosed. The partnership aims to boost the commercialization of Takeda’s Takepron (lansoprazole), Pantoloc (pantoprazole), and Prevacid (lansoprazole) in China.
Previous Collaboration
The two companies previously partnered in 2017 for the retail channel commercialization of multiple digestive prescription brands. This latest partnership is expected to further strengthen their collaboration in the Chinese market.-Fineline Info & Tech
